HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.

Abstract
The type II transmembrane serine proteases (TTSP) are cell surface proteolytic enzymes that mediate a diverse range of cellular functions, including tumour invasion and metastasis. Matriptase-2 is a member of the TTSP family and has been shown to have a key role in cancer progression. The role of matriptase-2 in angiogenesis and angiogenesis-related cancer progression is currently poorly understood. This study aims to elucidate the role of matriptase-2 in tumour angiogenesis. Matriptase-2 was over-expressed in human vascular endothelial cells, HECV, using a mammalian expression plasmid. The altered cells were used in a number of in vitro and in vivo assays designed to investigate the involvement of matriptase-2 in angiogenesis. Over-expression had no significant effect on the growth and adhesion of HECV cells. However, there was a significant reduction in the motility of the cells and their ability to form tubules in an artificial basement membrane (p < 0.01 for both). HECV(mat2 exp) cells inoculated into CD-1 athymic mice along with either PC-3 prostate cancer cells or MDA-MB-231 breast cancer cells showed a dramatic decrease in tumour development and growth in the prostate tumours (p < 0.01) and a lesser, non-significant, decrease in the breast tumours (p = 0.08). Over-expression of matriptase-2 also decreased urokinase type plasminogen activator total protein levels in HECV and prostate cells. The study concludes that matriptase-2 has the ability to suppress the angiogenic nature of HECV cells in vitro and in vivo. It also suggests that matriptase-2 could have a potential role in prostate and breast tumour suppression through its anti-angiogenic properties.
AuthorsSiobhan L Webb, Andrew J Sanders, Malcolm D Mason, Wen G Jiang
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 375 Issue 1-2 Pg. 207-17 (Mar 2013) ISSN: 1573-4919 [Electronic] Netherlands
PMID23238872 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Membrane Proteins
  • Serine Endopeptidases
  • matriptase 2
  • Urokinase-Type Plasminogen Activator
Topics
  • Animals
  • Cell Adhesion
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Endothelial Cells (physiology)
  • Endothelium, Vascular (pathology)
  • Gene Expression
  • Genes, Tumor Suppressor
  • Humans
  • Membrane Proteins (genetics, metabolism, physiology)
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms (blood supply)
  • Neovascularization, Pathologic (enzymology)
  • Serine Endopeptidases (genetics, metabolism, physiology)
  • Urokinase-Type Plasminogen Activator (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: